Hypothyroidism: A Closer Look

Hypothyroidism: A Closer Look

Levothyroxine is generally continued for life in these patients see WARNINGS AND PRECAUTIONS. Carefully monitor glycemic control after starting, changing, or discontinuing SYNTHROID see DRUG INTERACTIONS. Toxic effects may include increased risk of cardiac arrhythmias and central nervous system stimulation.

Because of the increased prevalence of cardiovascular disease among the elderly, initiate SYNTHROID at less than the full replacement dose see Dosage and Administration (2.3) and Warnings and Precautions (5.2). Atrial fibrillation is the most common of the arrhythmias observed with levothyroxine overtreatment in the elderly. For adult patients with primary hypothyroidism, titrate until the patient is clinically euthyroid and the serum TSH returns to normal. Initiate SYNTHROID therapy in this population at lower doses than those recommended in younger individuals or in patients without cardiac disease see DOSAGE AND ADMINISTRATION and Use In Specific Populations. Rapid restoration of normal serum T4 concentrations is essential for preventing the adverse effects of congenital hypothyroidism on cognitive development as well as on overall physical growth and maturation.

Use the serum free-T4 level to titrate SYNTHROID dosing until the patient is clinically euthyroid and the serum free-T4 level is restored to the upper half of the normal range see Dosage and Administration (2.3). Thyroid hormones, including SYNTHROID, either alone or with other therapeutic agents, should not be used for the treatment of obesity or for weight loss. In euthyroid patients, doses within the range of daily hormonal requirements are ineffective for weight reduction. Larger doses may produce serious or even life-threatening manifestations of toxicity, particularly when given in association with sympathomimetic amines such as those used for their anorectic effects. Use the serum free-T4 level to titrate SYNTHROID dosing until the patient is clinically euthyroid and the serum free-T4 level is restored to the upper half of the normal range.

Adverse Reactions In Pediatric Patients

Nephrosis, severe hypoproteinemia, severe synthroid depletion liver disease, acromegaly, androgens, and corticosteroids decrease TBG concentration. Familial hyper- or hypo-thyroxine binding globulinemias have been described, with the incidence of TBG deficiency approximating 1 in 9000. Concurrent use of tyrosine-kinase inhibitors such as imatinib may cause hypothyroidism. Monitor serum free-T4 levels and maintain in the upper half of the normal range in these patients. Patients The SYNTHROID dosage is based on the target level of TSH suppression for the stage and clinical status of thyroid cancer.

Antidepressant Therapy

Since postpartum TSH levels are similar to preconception values, the SYNTHROID dosage should return to the pre-pregnancy dose immediately after delivery see DOSAGE AND ADMINISTRATION. Consumption of certain foods may affect SYNTHROID absorption thereby necessitating adjustments in dosing see DOSAGE AND ADMINISTRATION. Start at a lower starting dosage and increase the dosage every 4 to 6 weeks as needed based on clinical and laboratory response. Many drugs can inhibit Synthroid’s adsorption by the body; other medications may increase or decrease its effectiveness once it is adsorbed.

In adult patients with primary hypothyroidism, monitor serum TSH levels after an interval of 6 to 8 weeks after any change in dosage. In patients on a stable and appropriate replacement dosage, evaluate clinical and biochemical response every 6 to 12 months and whenever there is a change in the patient’s clinical status. Absorption of orally administered T4 from the gastrointestinal tract ranges from 40% to 80%. The majority of the SYNTHROID dose is absorbed from the jejunum and upper ileum. The relative bioavailability of SYNTHROID tablets, compared to an equal nominal dose of oral levothyroxine sodium solution, is approximately 93%. T4 absorption is increased by fasting, and decreased in malabsorption syndromes and by certain foods such as soybeans.

Levoxyl treats hypothyroidism (low thyroid hormone) and treats or prevents goiter. You may not be able to take Synthroid if you have certain medical conditions. Tell your doctor if you have an untreated or uncontrolled adrenal gland disorder, a thyroid disorder called thyrotoxicosis, or if you have any recent or current symptoms of a heart attack. The hypothalamus, located in the brain, produces thyrotropin-releasing hormone (TRH) that tells the pituitary gland to make thyroid-stimulating hormone (TSH). TSH is produced by a small gland in the brain called the pituitary and can be measured by a common blood test.

  • The estimated background risk of major birth defects and miscarriage for the indicated population is unknown.
  • A high level of TSH plus low thyroid hormone levels indicates hypothyroidism.
  • Get medical help right away, if you have any of the symptoms listed above.
  • All pregnancies have a background risk of birth defect, loss, or other adverse outcomes.

Monitor patients receiving concomitant SYNTHROID and sympathomimetic agents for signs and symptoms of coronary insufficiency. The recommended daily dosage of SYNTHROID in pregnant patients is described in Table 3. Synthroid is a thyroid medicine that replaces a hormone normally produced by your thyroid gland to regulate the body’s energy and metabolism. Biotin supplementation is known to interfere with thyroid hormone immunoassays that are based on a biotin and streptavidin interaction, which may result in erroneous thyroid hormone test results. Stop biotin and biotin-containing supplements for at least 2 days prior to thyroid testing.

Since postpartum TSH levels are similar to preconception values, the SYNTHROID dosage should return to the pre-pregnancy dose immediately after delivery see Dosage and Administration (2.3). Because the thyroid can’t respond properly, the hypothalamus sends out more TRH and the pituitary keeps releasing more TSH. A high level of TSH plus low thyroid hormone levels indicates hypothyroidism.

Dr. Frieze suggests educating patients on the importance of consistent therapy & precise dosing with Synthroid. You are encouraged to report negative side effects of prescription drugs to the FDA. If cardiac symptoms develop or worsen, reduce the SYNTHROID dose or withhold for one week and restart at a lower dose. Seizures have been reported rarely with the institution of levothyroxine therapy. In order for Synthroid to be effective, it should always be taken the same way every day. This is important because the amount of medicine you need is very precise.